Drug Shortage Report for RELISTOR

Last updated on 2019-01-31 History
Report ID 12396
Drug Identification Number 02308215
Brand name RELISTOR
Common or Proper name Relistor
Company Name SALIX PHARMACEUTICALS INC
Active Ingredient(s) METHYLNALTREXONE BROMIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size One vial in a carton (each vial contains 12 mg/0.6 mL)
ATC code A06AH
ATC description DRUGS FOR CONSTIPATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2016-08-01
Actual start date
Estimated end date 2019-12-15
Actual end date
Shortage status Actual shortage
Updated date 2019-01-31
Company comments
Health Canada comments
Contact Address 400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER, NEW JERSEY
UNITED STATES 08807
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2019-01-31 French Compare
v15 2019-01-31 English Compare
v14 2018-11-29 French Compare
v13 2018-11-29 English Compare
v12 2018-10-09 French Compare
v11 2018-10-09 French Compare
v10 2018-10-09 English Compare
v9 2018-10-09 English Compare
v8 2018-05-24 French Compare
v7 2018-05-24 English Compare
v6 2018-01-05 French Compare
v5 2018-01-05 English Compare
v4 2017-12-28 French Compare
v3 2017-12-28 English Compare
v2 2017-06-09 French Compare
v1 2017-06-09 English Compare